Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab in advanced esophageal cancer
NCT02569242Phase 3Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Dec 2015
- Primary completion
- Oct 2020
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 3 trial of nivolumab in esophageal cancer, sponsored by Ono Pharmaceutical. Started Dec 2015; status: completed.
02
Drugs
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT02569242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02569242.